This federal contract award, valued at $654,181.14, was issued by the National Center for Advancing Translational Sciences, a civilian agency under the U.S. Department of Health and Human Services. The contract was awarded to MPF Federal, LLC, a certified HUBZone, Woman-Owned, Minority-Owned Small Disadvantaged Business, to provide regulatory support for BITOX, a detoxified form of botulism neurotoxin (BONT), as a treatment for chronic neuropathic pains focusing on osteoarthritis, a degenerative joint disease.
The contract is structured as a Delivery Order with a Labor Hours pricing type and has an ultimate completion date of September 21, 2026. MPF Federal, LLC holds several significant Indefinite Delivery Vehicles (IDVs) with the National Institutes of Health and the Department of Energy, allowing the company to provide a broad spectrum of services across the federal government. This particular contract award was not set aside for any specific socioeconomic program.
Generated 9/18/24, 10:02 AM